Targeting Fused in Sarcoma (FUS): A Novel Antisense Strategy for Treating Idiopathic Pulmonary Fibrosis
RNA-seq (gene expression) · human · 38 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 38 samples: 6 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosisSignal transduction and targeted therapy · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE310479_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1366387 and SRA study SRP646858. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 22 samples.
How we read this: 6 replicated groups read from 38 sample titles; they account for 22 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9301855 DO538-Input_1
- GSM9301856 DO540-Input_1
- GSM9301857 DO545-Input_1
- GSM9301858 DO546-Input_1
- GSM9301859 IPF381-Input_1
- GSM9301860 IPF384-Input_1
- GSM9301861 IPF389-Input_1
- GSM9301862 IPF530-Input_1
- GSM9301863 DO538-IP_1
- GSM9301864 DO540-IP_1
- GSM9301865 DO545-IP_1
- GSM9301866 DO546-IP_1
- GSM9301867 IPF381-IP_1
- GSM9301868 IPF384-IP_1
- GSM9301869 IPF389-IP_1
- GSM9301870 IPF530-IP_1
- GSM9301919 scr-ION-363_1 scr-ION-363
- GSM9301920 scr-ION-363_2 scr-ION-363
- GSM9301921 scr-ION-363_3 scr-ION-363
- GSM9301922 scr-ION-363_4 scr-ION-363
- GSM9301923 ION-363_1 ION-363
- GSM9301924 ION-363_2 ION-363
- GSM9301925 ION-363_3 ION-363
- GSM9301926 ION-363_4 ION-363
- GSM9301927 scr-siFUS_1 scr-siFUS
- GSM9301928 scr-siFUS_2 scr-siFUS
- GSM9301929 scr-siFUS_3 scr-siFUS
- GSM9301930 scr-siFUS_4 scr-siFUS
- GSM9301931 siFUS_1 siFUS
- GSM9301932 siFUS_2 siFUS
- GSM9301933 siFUS_3 siFUS
- GSM9301934 siFUS_4 siFUS
- GSM9301975 Scr_1 Sc
- GSM9301976 Scr_2 Sc
- GSM9301977 Scr_3 Sc
- GSM9301978 ASO_1 ASO
- GSM9301979 ASO_2 ASO
- GSM9301980 ASO_3 ASO
- GSE215274 Identification of Whole Blood Gene Expression Signature to Predict the Therapeutic Effect of Nintedanib in Idiopathic Pulmonary Fibrosis 177 samples shares idiopathic, pulmonary, fibrosis
- GSE326573 T-cell Multiomic Analysis Identifies Subsets and Mechanisms of Interaction with Epithelial Cells in Idiopathic Pulmonary Fibrosis 59 samples shares idiopathic, pulmonary, fibrosis
- GSE233844 Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis 38 samples shares idiopathic, pulmonary, fibrosis
- GSE272972 Critical role for the TGF-β1/mTORC1 signalling axis in defining the transcriptional identity of CTHRC1+ pathologic fibroblasts in idiopathic pulmonary fibrosis 18 samples shares idiopathic, pulmonary, fibrosis
- GSE314949 RNA Seq of rhabdomyosarcoma cells with sgRNA targeting oncofusion interacting proteins 30 samples shares fus, targeting
- GSE217494 Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis I 44 samples shares targeting, fibrosis
- GSE218391 Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis II 21 samples shares targeting, fibrosis
- GSE293580 Single-cell transcriptomics reveal diverging pathobiology and opportunities for precision targeting in scleroderma -associated versus idiopathic PAH 12 samples shares idiopathic, targeting
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.